Cumulus Neuroscience
Belfast
About Cumulus Neuroscience
Cumulus Neuroscience develops an AI-based digital biomarker platform to aid in the resolution of the most pressing healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience's platform is intended to provide the critical data and insight required for more rapid, robust, and cost-effective clinical trials that improve patient access to new therapies. The platform's novel insights change the future of clinical trials in brain disorders, allowing life-changing therapies to reach patients faster and more affordably.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.9M
- Last round: Series Unknown (Jul 2025)
- Website: cumulusneuro.com
- Phone: +44 (0)28 9264 6600
Industries & Categories
Health Care, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/cumulus-neuroscience-95213 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.